[{"data":1,"prerenderedAt":473},["ShallowReactive",2],{"blog-post-understanding-nanome-2.0's-new-permissioning-system:-a-guide-to-secure-and-collaborative-workspaces":3,"blog-posts-nav":22},{"data":4,"meta":18},[5],{"id":6,"attributes":7},34,{"title":8,"content":9,"createdAt":10,"updatedAt":11,"publishedAt":12,"date":13,"description":14,"keywords":15,"slug":16,"category":17},"Understanding Nanome 2.0’s New Permissioning System: A Guide to Secure and Collaborative Workspaces","**Understanding Nanome 2.0’s New Permissioning System: A Guide to Secure and Collaborative Workspaces**\n\n\n\u003Ca href=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Ftop_bar_c438d07552.png\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Ftop_bar_c438d07552.png\" style=\"width:100%; height:auto;\">\u003C\u002Fa>\n\n\n\nIn the realm of structure based drug discovery,, collaboration and data security are paramount. With the release of Nanome 2.0, we’ve introduced an entirely new **Permissioning System** designed to give you granular control over your workspaces and how you share them with others. In this blog post, we’ll explore the new permissioning system in detail, explaining the roles of Viewer, Editor, and Owner, and how you can effectively manage permissions to create a secure and collaborative environment.\n\n**The Importance of Permissions in Collaborative Workflows**\n\nWhen working with sensitive data or proprietary research, it’s crucial to ensure that only authorized individuals have access to your workspaces. At the same time, collaboration is essential for advancing scientific discoveries. Nanome’s new permissioning system covers both security and collaboration, giving you control over who can view, edit, or manage your workspaces.\n\n\u003Ca href=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fpermissions_1ede09c584.png\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fpermissions_1ede09c584.png\" style=\"width:100%; height:auto;\">\u003C\u002Fa>\n\n**Overview of the Permission Levels**\n\n**1. Viewer**\n\n\n\n* **Capabilities**:\n    * Can **see structures** within the workspace.\n    * Can **spotlight their view** to share their perspective with others.\n    * Can **follow others** to see what they are viewing.\n    * Can **navigate between scenes**.\n* **Restrictions**:\n    * **Cannot edit** representations or structures.\n    * **Cannot arrange** structures within the workspace.\n    * **Cannot invite** others to the workspace.\n\n**2. Editor**\n\n\n\n* **Capabilities**:\n    * **All Viewer permissions**, plus-\n    * Can **edit representations**, changing how molecules are visualized.\n    * Can **arrange structures**, repositioning molecules within the workspace.\n    * Can **invite others** to the workspace as Viewers or Editors.\n* **Restrictions**:\n    * **Cannot delete** the workspace.\n    * **Cannot change ownership** of the workspace.\n\n**3. Owner**\n\n\n\n* **Capabilities**:\n    * **All Editor permissions**, plus:\n    * Can **delete the workspace**.\n    * Has ultimate control over the workspace and its contents.\n* **Restrictions**:\n    * There can be **only one Owner** per workspace.\n    * Responsible for managing overall permissions and workspace settings.\n\n**Managing Permissions in Nanome 2.0**\n\n**Setting Workspace Permissions**\n\n\u003Ca href=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fpermissions_e4b50109c8.gif\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fpermissions_e4b50109c8.gif\" style=\"width:100%; height:auto;\">\u003C\u002Fa>\n\nWhen you create a new workspace or load an existing one, you can set the permissions for that workspace as a whole:\n\n\n\n* **Private (None)**: The workspace is only accessible to you. Others cannot join unless invited.\n* **Viewer**: Allows others to view the workspace with Viewer permissions.\n* **Editor**: Allows others to join with Editor permissions.\n\n**Inviting Collaborators**\n\n\n\nAs an Owner,  you can also set the permissions for collaborators you invite to your workspace:\n\n\n\n1. **Open the Collaboration Menu**: Navigate to the **Collaboration** option in the Application Menu.\n2. **Access Permissions**: Click on **Permissions** to manage who has access to your workspace.\n3. **Invite by Code**:\n    1. **Set the Workspace Code**: Change the code from **Private** to **Viewer** or **Editor** based on your needs.\n    2. **Share the Code**: Provide the code to your collaborators so they can join the workspace.\n4. **Invite by Email**:\n    3. **Enter Email Address**: Type the exact email associated with your collaborator’s Nanome account.\n    4. **Select Permission Level**: Choose whether they should join as a Viewer or Editor.\n    5. **Send Invitation**: The user will receive an invitation to join your workspace.\n\n**Managing Collaborator Permissions**\n\n\n\n* **View Current Collaborators**: In the Permissions section, you’ll see a list of users who have access to the workspace.\n* **Adjust Individual Permissions**:\n    * **Change Roles**: You can upgrade a Viewer to an Editor or downgrade an Editor to a Viewer as needed.\n    * **Revoke Access**: Set a user’s permission to **None** to remove their access to the workspace.\n\n**Understanding Load Options**\n\nWhen loading a workspace, you have two options:\n\n\n\n* **Load for All**:\n    * **Brings Everyone with You**: All participants in your current session will transition to the new workspace.\n    * **Set Permissions**: You may be prompted to assign permissions to users who don’t already have them.\n    * **Participant Notifications**: Users will see a progress notification with the option to opt-out or join immediately.\n* **Load**:\n    * **Solo Transition**: Only you will move to the new workspace.\n    * **Others Remain**: Participants will stay in the original workspace unless they choose to join you later.\n\n**Best Practices for Secure Collaboration**\n\n\n\n* **Assign Appropriate Permissions**: Only grant Editor permissions to users who need to modify structures or representations.\n* **Regularly Review Access**: Periodically check the list of collaborators and adjust permissions as projects evolve.\n* **Use Private Workspaces for Sensitive Data**: Keep workspaces set to Private when working on proprietary or confidential research.\n* **Communicate with Your Team**: Ensure all collaborators understand their permissions and responsibilities within the workspace.\n* **Delete Workspaces that are No Longer in Use:**  Remember, only Owners can delete workspaces.  .\n\n\n\n**Scenarios and Applications**\n\n**Collaborative Research Projects**\n\nFor team projects where multiple researchers need to analyze and manipulate molecular structures:\n\n\n\n* **Assign Editors**: Key team members can be given Editor permissions to contribute actively.\n* **Assign Viewers**: Stakeholders or advisors can join as Viewers to observe progress without altering data.\n\n**Educational Settings**\n\nIn a classroom or workshop environment:\n\n\n\n* **Instructor as Owner**: The instructor maintains control over the workspace.\n* **Students as Viewers**: Participants can explore the structures and follow along with the lesson.\n* **Interactive Sessions**: Temporarily elevate students to Editors for hands-on activities, then revert to Viewer after.\n\n**Presentations and Demonstrations**\n\nWhen showcasing findings to an audience:\n\n\n\n* **Use Load for All**: Ensure everyone is viewing the same workspace.\n* **Spotlight Feature**: Guide viewers through your presentation by spotlighting key structures or scenes.\n* **Maintain Control**: Keep participants as Viewers to prevent unintended changes.\n\n\u003Ca href=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fspotlight_follow_9f5f89378f.gif\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fspotlight_follow_9f5f89378f.gif\" style=\"width:100%; height:auto;\">\u003C\u002Fa>\n\n\n**Conclusion**\n\nNanome 2.0’s new permissioning system offers a robust and flexible framework for managing collaborative workspaces. By understanding and utilizing Viewer, Editor, and Owner roles effectively, you can create a secure environment that fosters collaboration while protecting your valuable research.\n\nWhether you’re leading a research team, teaching a class, or presenting to stakeholders, the ability to control access and permissions ensures that your work in Nanome is both productive and secure.\n\n**Experience the enhanced collaboration features today**! Get started with the Nanome AI Early Access Package: [https:\u002F\u002Fnanome.ai\u002Fnanome-ai\u002F](https:\u002F\u002Fnanome.ai\u002Fnanome-ai\u002F)\n","2024-10-29T05:13:24.035Z","2026-03-24T17:53:29.175Z","2024-10-29T05:16:14.034Z","2024-10-31","\t1.\tExplore Nanome 2.0’s New Permissioning System for Secure Collaboration – Discover how Nanome 2.0’s advanced Permissioning System helps scientists securely manage workspaces with Viewer, Editor, and Owner roles, fostering structured collaboration in drug discovery workflows.\n","Nanome 2.0, permissioning system, molecular collaboration, drug discovery, drug hunter, secure workspaces, computational chemistry, med chem, structure-based drug design, scientific collaboration, molecular visualization, Viewer Editor Owner roles, molecular research security, workspace management, collaborative science, Nanome AI, scientific permissions, VR in drug discovery, AI in drug discovery, secure data sharing","understanding-nanome-2.0's-new-permissioning-system:-a-guide-to-secure-and-collaborative-workspaces","tutorials",{"pagination":19},{"page":20,"pageSize":21,"pageCount":20,"total":20},1,100,{"data":23,"meta":471},[24,29,35,40,45,50,55,60,65,70,75,81,86,91,96,101,106,111,116,121,126,131,136,141,146,152,157,162,167,172,177,182,187,189,194,199,204,209,214,219,224,229,234,239,244,249,254,259,264,269,274,279,284,289,294,299,305,310,315,320,325,330,335,340,346,351,356,361,366,371,376,381,386,391,396,401,406,411,416,421,426,431,436,441,446,451,456,461,466],{"id":20,"attributes":25},{"slug":26,"title":27,"category":28},"spy-stories-and-rational-drug-design","Spy stories & rational drug design","case-studies",{"id":30,"attributes":31},2,{"slug":32,"title":33,"category":34},"meta-quest-pro-and-a-new-version-of-nanome-(v1.24)","Meta Quest Pro & a new version of Nanome (v1.24)","releases",{"id":36,"attributes":37},3,{"slug":38,"title":39,"category":28},"beating-the-pandemic-in-virtual-reality","Beating the Pandemic in Virtual Reality",{"id":41,"attributes":42},4,{"slug":43,"title":44,"category":28},"a-new-era-in-drug-discovery-the-first-ai-generated-drug-is-going-to-clinical-trial","A new era in drug discovery? The first AI-generated drug is going to clinical trial",{"id":46,"attributes":47},5,{"slug":48,"title":49,"category":28},"antibody-prophylaxis-for-lyme-disease","Antibody Prophylaxis for Lyme Disease",{"id":51,"attributes":52},6,{"slug":53,"title":54,"category":28},"diabetes-treatment-is-about-to-change-forever","Diabetes treatment is about to change forever",{"id":56,"attributes":57},7,{"slug":58,"title":59,"category":34},"april-2023-nanome-plugins-and-home.nanome.ai-updates","April 2023 Nanome Plugins & home.nanome.ai Updates",{"id":61,"attributes":62},8,{"slug":63,"title":64,"category":34},"v1.24.4-patch-release-blog-and-data-table-plugin-update","v1.24.4 Patch Release Blog and Data Table Plugin Update",{"id":66,"attributes":67},9,{"slug":68,"title":69,"category":28},"exploring-gaba-in-vr-common-therapeutics-can-reverse-pathological-sleep-conditions","Exploring GABA in VR - Common therapeutics can reverse pathological sleep conditions",{"id":71,"attributes":72},10,{"slug":73,"title":74,"category":34},"introducing-mara:-a-paradigm-shift-in-ai-assisted-scientific-informatics-workflow-orchestration","Introducing MARA: A Paradigm Shift in AI-assisted Scientific Informatics Workflow Orchestration",{"id":76,"attributes":77},11,{"slug":78,"title":79,"category":80},"reflecting-on-2023-and-looking-forward-to-2024","Reflecting on 2023, and looking forward to 2024","philosophy",{"id":82,"attributes":83},12,{"slug":84,"title":85,"category":80},"our-thoughts-on-the-up-and-coming-apple-vision-pro","Our thoughts on the up & coming Apple Vision Pro ",{"id":87,"attributes":88},13,{"slug":89,"title":90,"category":17},"revolutionize-your-research-with-the-nanome-jupyter-cookbook-plugin","Revolutionize Your Research with the Nanome Jupyter Cookbook Plugin",{"id":92,"attributes":93},14,{"slug":94,"title":95,"category":34},"introducing-the-the-nanome-scene-viewer-plugin","Introducing the The Nanome Scene Viewer Plugin",{"id":97,"attributes":98},15,{"slug":99,"title":100,"category":80},"nanospin:-a-glimpse-into-nanome's-vision-for-the-future-with-apple-vision-pro","NanoSpin: A Glimpse into Nanome's Vision for the Future with Apple Vision Pro",{"id":102,"attributes":103},16,{"slug":104,"title":105,"category":34},"calcflow-comes-to-the-apple-vision-pro","Calcflow comes to the Apple Vision Pro",{"id":107,"attributes":108},17,{"slug":109,"title":110,"category":34},"nanome-apple-vision-pro-and-2.0-dev-blog-april-2024","Nanome Apple Vision Pro & 2.0 Dev Blog April 2024",{"id":112,"attributes":113},18,{"slug":114,"title":115,"category":34},"mara-q2-2024-update-blog","MARA Q2 2024 Update Blog",{"id":117,"attributes":118},19,{"slug":119,"title":120,"category":80},"nanome-on-apple-vision-pro-roadmap","Nanome on Apple Vision Pro Roadmap",{"id":122,"attributes":123},20,{"slug":124,"title":125,"category":34},"v1.24.6-patch-release","v1.24.6 Patch Release",{"id":127,"attributes":128},21,{"slug":129,"title":130,"category":34},"mara-public-beta-coming-soon","MARA Public Beta Coming Soon ",{"id":132,"attributes":133},22,{"slug":134,"title":135,"category":34},"introduction-to-mara-freemium","Introduction to MARA Freemium",{"id":137,"attributes":138},23,{"slug":139,"title":140,"category":17},"computer-aided-drug-discovery-and-design-through-mara","Computer-Aided Drug Discovery & Design through MARA",{"id":142,"attributes":143},24,{"slug":144,"title":145,"category":17},"mara-and-cdd-integration-example","MARA & CDD Integration Example",{"id":147,"attributes":148},26,{"slug":149,"title":150,"category":151},"collaborative-drug-discovery-and-nanome-partnership-announcement","Collaborative Drug Discovery & Nanome Partnership Announcement","partnerships",{"id":153,"attributes":154},25,{"slug":155,"title":156,"category":17},"introduction-to-mara-tool-creation","Introduction to MARA Tool Creation",{"id":158,"attributes":159},27,{"slug":160,"title":161,"category":34},"mara-update:-v0.12.10","MARA Update: v0.12.10",{"id":163,"attributes":164},28,{"slug":165,"title":166,"category":17},"mara-bioinformatics-workflow","MARA Bioinformatics Workflow",{"id":168,"attributes":169},29,{"slug":170,"title":171,"category":17},"mara-cheminformatics-workflow","MARA Cheminformatics Workflow",{"id":173,"attributes":174},32,{"slug":175,"title":176,"category":34},"announcing-the-early-access-program-for-nanome-ai:-the-next-generation-of-molecular-design","Announcing the Early Access Program for Nanome AI: The Next Generation of Molecular Design",{"id":178,"attributes":179},31,{"slug":180,"title":181,"category":17},"mara-and-jupyter-notebook-integration","MARA and Jupyter Notebook Integration",{"id":183,"attributes":184},33,{"slug":185,"title":186,"category":17},"exploring-the-new-scene-menu-in-nanome-2.0:-a-comprehensive-guide","Exploring the New Scene Menu in Nanome 2.0: A Comprehensive Guide",{"id":6,"attributes":188},{"slug":16,"title":8,"category":17},{"id":190,"attributes":191},35,{"slug":192,"title":193,"category":17},"nanome-2.0:-a-deep-dive-into-the-technical-foundations","Nanome 2.0: A Deep Dive into the Technical Foundations",{"id":195,"attributes":196},36,{"slug":197,"title":198,"category":34},"major-updates-to-the-nanome-documentation-site","Major Updates to the Nanome Documentation Site",{"id":200,"attributes":201},37,{"slug":202,"title":203,"category":17},"assay-data-enabled-analysis-workflows-in-mara","Assay Data Enabled Analysis Workflows in MARA",{"id":205,"attributes":206},38,{"slug":207,"title":208,"category":17},"from-vault-to-workspaces:-the-evolution-of-file-and-workflow-management-in-nanome-2.0","From Vault to Workspaces: The Evolution of File and Workflow Management in Nanome 2.0",{"id":210,"attributes":211},39,{"slug":212,"title":213,"category":80},"looking-back-at-2024-and-what's-next-for-nanome-in-2025","Looking Back at 2024 and What’s Next for Nanome in 2025",{"id":215,"attributes":216},40,{"slug":217,"title":218,"category":17},"how-nanome's-agentic-platform-can-enhance-and-integrate-with-your-docking-and-structural-visualization-workflows","How Nanome’s agentic platform can enhance and integrate with your docking and structural visualization workflows",{"id":220,"attributes":221},41,{"slug":222,"title":223,"category":34},"nanome-ai-february-2025-update!","Nanome AI February 2025 Update!",{"id":225,"attributes":226},42,{"slug":227,"title":228,"category":34},"mara's-updated-workflow-processes-provide-huge-time-savings!","MARA’s Updated Workflow Processes Provide Huge Time Savings!",{"id":230,"attributes":231},43,{"slug":232,"title":233,"category":151},"livedesign-live-reports-literally-at-your-fingertips","LiveDesign Live Reports — Literally at Your Fingertips",{"id":235,"attributes":236},44,{"slug":237,"title":238,"category":34},"nanome-v2.1.0-release-update:-new-workspace-api-interactions-alignment-ligands-table-and-more!","Nanome v2.1.0 Release Update: New Workspace API, Interactions, Alignment, Ligands Table, and more!",{"id":240,"attributes":241},45,{"slug":242,"title":243,"category":151},"view-your-openeyecadence-data-with-fresh-eyes-using-nanome-xr","View Your OpenEye\u002FCadence Data with Fresh Eyes using Nanome XR",{"id":245,"attributes":246},46,{"slug":247,"title":248,"category":34},"nanome-v2.1.1-patch-release-update:-new-scene-pov-sdf-metadata-support-and-rendering-improvements","Nanome v2.1.1 Patch Release Update: New Scene POV, SDF Metadata Support, and Rendering Improvements",{"id":250,"attributes":251},47,{"slug":252,"title":253,"category":34},"nanome-v2.2.0:-measure-interact-and-analyze-from-atom-to-angstroms","Nanome v2.2.0: Measure, Interact, and Analyze from Atom to Angstroms",{"id":255,"attributes":256},48,{"slug":257,"title":258,"category":28},"v2.2-usecase-blog:-how-a-biochemist-leveraged-measurement-tools-in-xr-to-streamline-protein-design","V2.2 Usecase Blog: How a biochemist leveraged Measurement Tools in XR to Streamline Protein Design",{"id":260,"attributes":261},49,{"slug":262,"title":263,"category":151},"from-pdb-to-pose:-integration-of-nanome's-mara-and-cresset's-flare","From PDB to Pose: Integration of Nanome’s MARA and Cresset’s Flare",{"id":265,"attributes":266},50,{"slug":267,"title":268,"category":34},"nanome-v2.3.0:-new-tools-(builder-and-selection)-sequence-menu-and-web-preview","Nanome V2.3.0: New Tools (Builder and Selection), Sequence Menu, and Web Preview",{"id":270,"attributes":271},51,{"slug":272,"title":273,"category":34},"important-security-update-for-nanome-unity-vulnerability-patch","Important Security Update for Nanome – Unity Vulnerability Patch",{"id":275,"attributes":276},52,{"slug":277,"title":278,"category":80},"interface-to-design-the-future","Interface to Design the Future",{"id":280,"attributes":281},53,{"slug":282,"title":283,"category":17},"setting-up-boltz-2-configuration-files-and-analysis-with-nanome-ai","Setting Up Boltz-2 Configuration Files and Analysis with Nanome AI",{"id":285,"attributes":286},54,{"slug":287,"title":288,"category":151},"meta-horizon-managed-services-goes-free:-what-this-means-for-enterprise-vr-users","Meta Horizon Managed Services Goes Free: What This Means for Enterprise VR Users",{"id":290,"attributes":291},55,{"slug":292,"title":293,"category":34},"nanome-v2.4.0:-early-access-release-mara-voice-commands-minimization-chem-interactions-and-more!","Nanome v2.4.0: Early Access Release, Mara Voice Commands, Minimization, Chem Interactions, and more! ",{"id":295,"attributes":296},60,{"slug":297,"title":298,"category":151},"nanome-joins-the-openfold-consortium","Nanome Joins the OpenFold Consortium",{"id":300,"attributes":301},66,{"slug":302,"title":303,"category":304},"announcing:-nanome-claude-code-skill-and-mcp-server-and-what's-next-for-mara","Announcing: Nanome Claude Code Skill & MCP Server, and What's Next for MARA",null,{"id":306,"attributes":307},69,{"slug":308,"title":309,"category":80},"the-new-front-door-to-nanome","The New Front Door to Nanome",{"id":311,"attributes":312},68,{"slug":313,"title":314,"category":34},"nanome-v2.5:-web-trajectories-torsion-tool-and-more","Nanome v2.5: Web, Trajectories, Torsion Tool, and More",{"id":316,"attributes":317},70,{"slug":318,"title":319,"category":304},"academic-license-update-for-nanome","Academic License Update for Nanome",{"id":321,"attributes":322},71,{"slug":323,"title":324,"category":34},"web-app-1.0-ships-today-and-mara's-beta-tag-comes-off-with-it.","Web App 1.0 ships today, and MARA's beta tag comes off with it.",{"id":326,"attributes":327},138,{"slug":328,"title":329,"category":34},"v2.6-release-blog:-scene-recording-residue-editor-mara-tools-in-xr-and-more","V2.6 Release Blog: Scene Recording, Residue Editor, MARA Tools in XR, and More",{"id":331,"attributes":332},140,{"slug":333,"title":334,"category":28},"how-resonac-turned-two-years-of-misaligned-randd-into-a-single-afternoon-breakthrough","How Resonac Turned Two Years of Misaligned R&D Into a Single Afternoon Breakthrough",{"id":336,"attributes":337},141,{"slug":338,"title":339,"category":304},"nanome-mcp-is-live!","Nanome MCP is live!",{"id":341,"attributes":342},142,{"slug":343,"title":344,"category":345},"what-a-modern-molecular-presentation-looks-like","The molecular PowerPoint: what a modern molecular presentation looks like","frequent-topics",{"id":347,"attributes":348},102,{"slug":349,"title":350,"category":345},"how-to-view-pdb-files-in-3d-and-the-tools-that-do-it-well","How to view PDB files in 3D, and the tools that do it well",{"id":352,"attributes":353},90,{"slug":354,"title":355,"category":345},"molecular-visualization-for-structural-biologists","Molecular visualization for structural biologists",{"id":357,"attributes":358},83,{"slug":359,"title":360,"category":345},"collaborative-drug-discovery-software-for-remote-teams","Collaborative drug discovery software for remote teams",{"id":362,"attributes":363},85,{"slug":364,"title":365,"category":345},"how-to-analyze-protein-ligand-interactions","How to analyze protein-ligand interactions",{"id":367,"attributes":368},103,{"slug":369,"title":370,"category":345},"vr-for-medicinal-chemists","VR for medicinal chemists",{"id":372,"attributes":373},86,{"slug":374,"title":375,"category":345},"how-to-visualize-proteins-in-vr","How to visualize proteins in VR",{"id":377,"attributes":378},77,{"slug":379,"title":380,"category":345},"software-for-computational-antibody-design","Software for computational antibody design",{"id":382,"attributes":383},88,{"slug":384,"title":385,"category":345},"software-for-molecular-docking-visualization","Software for molecular docking visualization",{"id":387,"attributes":388},105,{"slug":389,"title":390,"category":345},"the-best-molecular-visualization-tools","The best molecular visualization tools",{"id":392,"attributes":393},84,{"slug":394,"title":395,"category":345},"drug-discovery-software-for-computational-chemistry","Drug discovery software for computational chemistry",{"id":397,"attributes":398},74,{"slug":399,"title":400,"category":345},"agentic-ai-for-computational-chemistry","Agentic AI for computational chemistry",{"id":402,"attributes":403},75,{"slug":404,"title":405,"category":345},"an-ai-copilot-for-drug-discovery-workflows","An AI copilot for drug discovery workflows",{"id":407,"attributes":408},87,{"slug":409,"title":410,"category":345},"mcp-servers-for-cheminformatics-and-drug-discovery","MCP servers for cheminformatics and drug discovery",{"id":412,"attributes":413},93,{"slug":414,"title":415,"category":345},"how-nanome-is-different-from-moe","How Nanome is different from MOE",{"id":417,"attributes":418},92,{"slug":419,"title":420,"category":345},"how-nanome-is-different-from-biovia-discovery-studio","How Nanome is different from BIOVIA Discovery Studio",{"id":422,"attributes":423},94,{"slug":424,"title":425,"category":345},"how-nanome-is-different-from-pymol","How Nanome is different from PyMOL",{"id":427,"attributes":428},95,{"slug":429,"title":430,"category":345},"how-nanome-is-different-from-schrodinger-maestro","How Nanome is different from Schrödinger Maestro",{"id":432,"attributes":433},91,{"slug":434,"title":435,"category":345},"how-nanome-is-different-from-ucsf-chimerax","How Nanome is different from UCSF ChimeraX",{"id":437,"attributes":438},145,{"slug":439,"title":440,"category":345},"how-to-run-an-sar-meeting","How to run an SAR meeting on a 3D structure",{"id":442,"attributes":443},96,{"slug":444,"title":445,"category":345},"how-nanome-is-different-from-vmd","How Nanome is different from VMD",{"id":447,"attributes":448},98,{"slug":449,"title":450,"category":345},"tools-for-visualizing-protein-ligand-interactions","Tools for visualizing protein-ligand interactions",{"id":452,"attributes":453},144,{"slug":454,"title":455,"category":345},"presenting-computational-results-to-experimental-teams","How to present computational results to an experimental team",{"id":457,"attributes":458},89,{"slug":459,"title":460,"category":345},"software-for-visualizing-molecular-dynamics-trajectories","Software for visualizing molecular dynamics trajectories",{"id":462,"attributes":463},143,{"slug":464,"title":465,"category":345},"how-to-share-a-3d-molecular-structure-with-your-team","How to share a 3D molecular structure with your team",{"id":467,"attributes":468},97,{"slug":469,"title":470,"category":345},"natural-language-interfaces-for-molecular-modeling","Natural language interfaces for molecular modeling",{"pagination":472},{"page":20,"pageSize":21,"pageCount":20,"total":457},1789488483850]